Here are relevant reports on : iv-equipment-market
-
IV Equipment Market by Type (IV Catheter, IV Administration Set, Needle-free Connectors), Application (Medication Administration, Parenteral Nutrition, Diagnostic Testing, Blood & Blood Product Transfusion), End User (Hospital) - Global Forecast to 2031
The IV Equipment market, valued at USD 16.85 billion in 2025, stood at USD 17.82 billion in 2026 and is projected to advance at a resilient CAGR of 6.1% from 2026 to 2031, culminating in a forecasted valuation of USD 23.92 billion by the end of the period. The IV equipment market is expected to grow significantly, driven by increasing cases of chronic diseases, rising hospitalizations, and an aging population.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Sharps Safety Devices Market by Product (Injection Equipment, Blood Collection Equipment, IV Insertion Equipment, Safety Lancets, Safety Scalpels, Safety Knives) & by Technology (Retractable and Passive) - Analysis & Global Forecasts to 2020
Healthcare regulations refer to sharp instruments as medical objects or instruments necessary for the exercise of specific health care activities such as making cuts or pricks. The users of these objects/instruments (the healthcare providers) bear a significant risk of injury and/or are susceptible to infections if the sharp is contaminated with infectious blood. Sharps injuries are primarily associated with occupational transmission of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV), but they have been implicated in the transmission of more than 20 other pathogens. Sharps safety devices have engineering controls that are built into the product and prevent sharps injuries.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Home Healthcare Market By Equipment (Oxygen delivery systems, CPAP, nebulizers, ventilators, IV diagnostics, home dialysis, insulin delivery devices, and other equipment)
In this report, we have analyzed how the home healthcare market is evolving. The increasing population above the age group of 65 years covers about 70% of the entire market, while the elderly support population (population between 20-64 years of age) is declining. The lack of family members to support and care for the elderly at home generates a high demand for home care products and services. Along with this, the increased cost of hospital care services presents the largest opportunity for this market. Thus, many companies are eagerly approaching this segment with several customized products and services.
- Published: February 2010
- Price: $ 4950
- TOC Available:
-
North American Home Healthcare Market By Product [Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit], Services [Respiratory Therapy, Rehabilitation Therapy] & Telehealth - Forecasts To 2017
The North America home health care market was valued at $90.9 billion in 2012; it is poised to grow at a CAGR of 7.5% to reach $130.4 billion by 2017. Home healthcare market includes products, services, and telehealth. The home care product category comprises homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, fitness, and nutrition products. Services include unskilled care, rehabilitation therapy, infusion therapy, and respiratory therapy, while telehealth includes home telehealth monitoring devices and telehealth services.
- Published: May 2013
- Price: $ 4950
- TOC Available:
-
European Home Healthcare Market By Products (Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit), Services (Respiratory Therapy, Rehabilitation Therapy) & Telehealth – Forecasts to 2017
The Europe home healthcare market is segmented as products, services, telehealth, and geography. The products market is further classified into homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, and nutrition and fitness. The home healthcare services market is further segmented into unskilled care, rehabilitation therapy, infusion therapy and respiratory therapy, while the telehealth market includes monitoring devices, services, and managed equipment services. The total market is divided into seven major countries, i.e. Germany, France, U.K., Italy Spain, Russia, and Rest of Europe (RoE).
- Published: July 2013
- Price: $ 4950
- TOC Available:
-
IV-Fluid Transfer Devices Market - 2019 By Types, Application & Geography
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Catheters Market by Type (Cardiovascular (Electrophysiology, Coronary Balloon, IVUS/OCT), Intravenous (CVC, PIVC, Midline), Urological, Neurovascular), Indication (Cardiac, Vascular, Kidney, Blood Transfusion, IV Medication Delivery and Fluid Management) - Global Forecast to 2030
The global catheters market, valued at US$28.51 billion in 2024, stood at US$30.53 billion in 2025 and is projected to advance at a resilient CAGR of 8.5% from 2025 to 2030, culminating in a forecasted valuation of US$45.99 billion by the end of the period.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Digital Biomarkers Market by Type (Physiological, Vocal, Idiosyncratic), Therapy [Cardio, Onco (Lung, Breast Cancer), Mental Health, Neuro], Application [Clinical Research (Phase IV)], End User (Pharma & Biotech Companies, CROs) – Global Forecast to 2031
The global digital biomarkers market is projected to reach USD 17.73 billion by 2031, growing at a CAGR of 19.1% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Asia-Pacific Base Oil Market by Type (Group I, Group II, Group III, Group IV, & Group V), by Application (Automotive, Industrial Application, & Others) - Trends & Forecast to 2020
The Asia-Pacific base oil market is estimated to register a CAGR of 3.5% between 2015 and 2020 and the demand is estimated to reach 25,226.5 KT by 2020. The demand for base oil is expected to witness a steady growth in the Asia-Pacific countries. The market size is expected to increase in Asia-Pacific, due to the economic growth in the nations such as South Korea, China, and India.
- Published: April 2015
- Price: $ 4950
- TOC Available:
-
Oligonucleotide Therapeutics Market by Molecule (Nusinersen, Vutrisiran, Inclisiran, Eteplisiran), Type (ASO, siRNA, Others), Disease Type (Neurology, Rare Diseases, Others), RoA (SC, Intrathecal, IV, Others), and Region - Global Forecast to 2030
The global oligonucleotide therapeutics market, valued at US$5.92 billion in 2024, stood at US$7.19 billion in 2025 and is projected to advance at a resilient CAGR of 19.7% from 2025 to 2030, culminating in a forecasted valuation of US$17.70 billion by the end of the period. The market is growing as more RNA-targeting therapies gain broader clinical acceptance. This increase is mainly driven by siRNAs and antisense candidates, supported by advances in delivery technologies like GalNAc conjugates and lipid nanoparticles.
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
